Sverre Erik Kjeldsen

Image of Sverre Erik Kjeldsen
Norwegian version of this page
Username
Visiting address Sem Sælands vei 3 Farmasibygningen 0371 Oslo
Postal address Postboks 1068 Blindern 0316 Oslo
Other affiliations Department of Pharmacy

Publications

View all works in Cristin

  • Burnier, Michel; Kjeldsen, Sverre; Narkiewicz, Krzysztof; Egan, Brent & Kreutz, Reinhold (2022). Hypertension management during the COVID-19 pandemic: what can we learn for the future? Blood Pressure. ISSN 0803-7051. 31(1), p. 47–49. doi: 10.1080/08037051.2022.2058909.
  • Burnier, Michel & Kjeldsen, Sverre (2022). A 30th anniversary and a glimpse of the future. Blood Pressure. ISSN 0803-7051. 31(1), p. 1–3. doi: 10.1080/08037051.2021.2021638.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2021). Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes–from single pill combinations to monitoring of a nationwide health insurance database. Blood Pressure. ISSN 0803-7051. 30(3), p. 143–144. doi: 10.1080/08037051.2021.1917192.
  • Burnier, Michel; Kjeldsen, Sverre; Narkiewicz, Krzysztof & Oparil, Suzanne (2021). Cuff-less measurements of blood pressure: are we ready for a change? Blood Pressure. ISSN 0803-7051. 30(4), p. 205–207. doi: 10.1080/08037051.2021.1956178.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2021). Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers. Blood Pressure. ISSN 0803-7051. 30(1), p. 1–3. doi: 10.1080/08037051.2021.1862483.
  • Gjesdal, Knut & Kjeldsen, Sverre (2021). Fusk og feil i forskning og forskningsformidling. Indremedisineren. ISSN 1891-1617. p. 54–57.
  • Kjeldsen, Sverre E.; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2021). The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug. Blood Pressure. ISSN 0803-7051. doi: 10.1080/08037051.2021.1995975.
  • Kreutz, Reinhold; Kjeldsen, Sverre E. & Mancia, Giuseppe (2021). Why we do not need a single independent international hypertension clinical practice guideline. Journal of Hypertension. ISSN 0263-6352. 39(11), p. 2125–2127. doi: 10.1097/HJH.0000000000002940.
  • Narkiewicz, Krzysztof; Burnier, Michel; Kjeldsen, Sverre & Oparil, Suzanne (2021). Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection. Blood Pressure. ISSN 0803-7051. 30(5), p. 267–268. doi: 10.1080/08037051.2021.1975878.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2020). Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines? Blood Pressure. ISSN 0803-7051. 29(6), p. 341–343. doi: 10.1080/08037051.2020.1838766.
  • Kreutz, Reinhold; Kjeldsen, Sverre; Burnier, Michel; Narkiewicz, Krzysztof; Oparil, Suzanne & Mancia, Giuseppe (2020). Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime. Journal of Hypertension. ISSN 0263-6352. 38(11), p. 2144–2145. doi: 10.1097/HJH.0000000000002671.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2020). The International Society of Hypertension Guidelines 2020–a new drug treatment recommendation in the wrong direction? Blood Pressure. ISSN 0803-7051. 29(5), p. 264–266. doi: 10.1080/08037051.2020.1806494.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2020). Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial? Blood Pressure. ISSN 0803-7051. 29(4), p. 199–201. doi: 10.1080/08037051.2020.1782595.
  • Kreutz, Reinhold; Kjeldsen, Sverre; Burnier, Michel; Narkiewicz, Krzysztof; Oparil, Suzanne & Mancia, Giuseppe (2020). Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. Blood Pressure. ISSN 0803-7051. 29(3), p. 135–136. doi: 10.1080/08037051.2020.1747696.
  • Kjeldsen, Sverre & Os, Ingrid (2020). Poor reproducibility of masked and white coat uncontrolled hypertension: Important new information on MUCH and WUCH. European Heart Journal. ISSN 0195-668X. 41(16), p. 1572–1574. doi: 10.1093/eurheartj/ehz703.
  • Burnier, Michel; Kjeldsen, Sverre; Narkiewicz, Krzysztof & Oparil, Suzanne (2020). How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers. Blood Pressure. ISSN 0803-7051. 29(2), p. 68–69. doi: 10.1080/08037051.2020.1726101.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2020). The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension. Blood Pressure. ISSN 0803-7051. 29(1), p. 1–2. doi: 10.1080/08037051.2020.1707440.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). Systolic blood pressure control prevents cognitive decline and slows development of white matter lesions in the brain: the SPRINT MIND study outcomes. Blood Pressure. ISSN 0803-7051. 28(6), p. 356–357. doi: 10.1080/08037051.2019.1678261.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). The PARAGON-Heart failure trial–another disappointment for heart failure patients with hypertension and preserved ejection fraction. Blood Pressure. ISSN 0803-7051. 28(5), p. 276–278. doi: 10.1080/08037051.2019.1664717.
  • Kjeldsen, Sverre & Os, Ingrid (2019). Are people with masked hypertension adherent to their antihypertensive medication? Hypertension. ISSN 0194-911X. 74(3), p. 497–498. doi: 10.1161/HYPERTENSIONAHA.119.13350.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). The PARAGON Heart Failure trial–ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction. Blood Pressure. ISSN 0803-7051. 28(4), p. 215–216. doi: 10.1080/08037051.2019.1625523.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited. Blood Pressure. ISSN 0803-7051. 28(3), p. 144–145. doi: 10.1080/08037051.2019.1614278.
  • Kjeldsen, Sverre; Atar, Dan & von Lueder, Thomas Gero (2019). Angiotensin receptor neprilysin inhibition for the treatment of hypertension: The neglected child in cardiovascular pharmacotherapy. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. ISSN 2055-6837. 5(2), p. 122–123. doi: 10.1093/ehjcvp/pvz005.
  • Kjeldsen, Sverre; Fadl Elmula, Fadl Elmula M. & Persu, Alexandre (2019). Future of Renal Sympathetic Denervation in the Treatment of Hypertension. Journal of the American College of Cardiology. ISSN 0735-1097. 73(13), p. 1643–1645. doi: 10.1016/j.jacc.2019.02.008.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2019). Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension? Blood Pressure. ISSN 0803-7051. 28(2), p. 75–76. doi: 10.1080/08037051.2019.1584975.
  • Burnier, Michel; Narkiewicz, Krzysztof; Kjeldsen, Sverre & Oparil, Suzanne (2019). New data on antihypertensive drugs and risk of cancer: should we worry? Blood Pressure. ISSN 0803-7051. 28(1), p. 1–3. doi: 10.1080/08037051.2019.1568182.
  • Kjeldsen, Sverre & Mancia, Giuseppe (2019). Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results. Journal of Hypertension. ISSN 0263-6352. 37(1), p. 6–8. doi: 10.1097/HJH.0000000000001874.
  • Kjeldsen, Sverre; Mariampillai, Julian Eek & Nilsson, Peter M. (2018). Optimal blood pressure target in diabetic and nondiabetic hypertensive patients. Circulation Research. ISSN 0009-7330. 123(5), p. 528–530. doi: 10.1161/CIRCRESAHA.118.312763.
  • Mehlum, Maria Hollund; Liestøl, Knut; Kjeldsen, Sverre & Berge, Eivind (2018). Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues. European Heart Journal. ISSN 0195-668X. 39(47), p. 4221–4221. doi: 10.1093/eurheartj/ehy605.
  • Kjeldsen, Sverre; Os, Ingrid & Nilsson, Peter M. (2018). Does intensive glucose control cancel out benefits of systolic blood pressure target <120 mmHg in patients with diabetes mellitus participating in accoRD? Hypertension. ISSN 0194-911X. 72(2), p. 291–293. doi: 10.1161/HYPERTENSIONAHA.118.11455.
  • Burnier, M.; Oparil, Suzanne; Narkiewicz, Krzysztof & Kjeldsen, Sverre (2018). New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden? Blood Pressure. ISSN 0803-7051. 27(2), p. 62–65. doi: 10.1080/08037051.2018.1430504.
  • Kjeldsen, Sverre & Esler, Murray D. (2018). Take a blood pressure pill or undergo renal denervation? The Lancet. ISSN 0140-6736. doi: 10.1016/S0140-6736%2818%2931126-7.
  • Narkiewicz, Krzysztof; Kjeldsen, Sverre; Burnier, Michel & Oparil, Suzanne (2018). Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions. Blood Pressure. ISSN 0803-7051. 27(1), p. 1–2. doi: 10.1080/08037051.2017.1407218.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials. Blood Pressure. ISSN 0803-7051. 26(5), p. 257–258. doi: 10.1080/08037051.2017.1357110.
  • Kjeldsen, Sverre; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke. Blood Pressure. ISSN 0803-7051. 26(3), p. 131–132. doi: 10.1080/08037051.2017.1292456.
  • Burnier, Michel; Narkiewicz, Krzysztof; Kjeldsen, Sverre & Oparil, Suzanne (2017). Renal denervation in hypertension: is it the end or the beginning of a SPYRAL? Blood Pressure. ISSN 0803-7051. 26(6), p. 319–320. doi: 10.1080/08037051.2017.1386539.
  • Messerli, Franz H.; Hofstetter, Louis; Agabiti-Rosei, Enrico; Burnier, Michel; Elliott, William J. & Franklin, Stanley S. [Show all 31 contributors for this article] (2017). Reply. Journal of Hypertension. ISSN 0263-6352. 35(11), p. 2327–2328. doi: 10.1097/HJH.0000000000001526.
  • Klemsdal, Tor Ole; Gjelsvik, Bjørn E.; Elling, Inger; Johansen, Sirin; Kjeldsen, Sverre Erik & Kristensen, Øivind [Show all 11 contributors for this article] (2017). Nye retningslinjer for forebygging av hjerte- og karsykdom. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 137(16), p. 1164–1168. doi: 10.4045/tidsskr.17.0109.
  • Messerli, Franz H.; Hofstetter, Louis; Agabiti-Rosei, Enrico; Burnier, Michel; Elliott, William J. & Franklin, Stanley S. [Show all 31 contributors for this article] (2017). Expertise: No longer a sine qua non for guideline authors? Journal of Hypertension. ISSN 0263-6352. 35(8), p. 1564–1566. doi: 10.1097/HJH.0000000000001435.
  • Messerli, Franz H.; Hofstetter, Louis; Agabiti-Rosei, Enrico; Burnier, Michel; Elliott, William J. & Franklin, Stanley S. [Show all 30 contributors for this article] (2017). Expertise: no longer a sine qua non for guideline authors? Hypertension. ISSN 0194-911X. 70(2), p. 235–237. doi: 10.1161/HYPERTENSIONAHA.117.09470.
  • Burnier, Michel; Narkiewicz, Krzysztof & Kjeldsen, Sverre Erik (2017). Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue? Blood Pressure. ISSN 0803-7051. 26(4), p. 193–194. doi: 10.1080/08037051.2017.1332478.
  • Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). The INTERSALT Study and the complex relationship between salt intake and blood pressure. Blood Pressure. ISSN 0803-7051. 26(2), p. 65–66. doi: 10.1080/08037051.2016.1274957.
  • Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof; Burnier, Michel & Oparil, Suzanne (2017). The Global Burden of Disease Study 2015 and Blood Pressure. Blood Pressure. ISSN 0803-7051. 26(1). doi: 10.1080/08037051.2016.1267557.
  • Messerli, Franz H.; Bangalore, Sripal & Kjeldsen, Sverre Erik (2017). Letter by Messerli et al Regarding Article, "the Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure". Circulation. ISSN 0009-7322. 135(7), p. e45–e46. doi: 10.1161/CIRCULATIONAHA.116.025301.
  • Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof & Oparil, Suzanne (2017). Blood Pressure in 2016: increased impact factor and change of editors. Blood Pressure. ISSN 0803-7051. 25(6), p. 331–332. doi: 10.1080/08037051.2016.1274957.
  • Kjeldsen, Sverre Erik; Hedner, Thomas & Narkiewicz, Krzysztof (2016). HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg. Blood Pressure. ISSN 0803-7051. 25(3), p. 131–132. doi: 10.1080/08037051.2016.1182857.
  • Kjeldsen, Sverre Erik & Lund-Johansen, Per (2016). Tynt grunnlag for å endre mål for blodtrykksbehandling. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 136(3), p. 209–210. doi: 10.4045/tidsskr.15.1298.
  • Hedner, Thomas; Kjeldsen, Sverre Erik; Narkiewicz, Krzysztof & Oparil, Suzanne (2016). The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease. Blood Pressure. ISSN 0803-7051. 25(5), p. 276–279. doi: 10.3109/08037051.2016.1139324.

View all works in Cristin

Published Apr. 13, 2011 2:55 PM - Last modified Oct. 2, 2020 11:57 AM